Glia Signalling during Neurological Damage and Disease


While glia were once thought to be nothing more than glue‐like cells that hold the nervous system together, there is growing evidence that signals to and from glia are indispensable for development, cell‐to‐cell communication and maintenance of efficient nervous system function. Several studies show that glia often receive conflicting signals during disease progression and can play dual roles as both antagonists and neuroprotectors in distinct settings.

Key Concepts

  • Glia play neuroprotective and neurodegenerative role during the initiation and progression stage of neurodegenerative diseases.
  • Astrocytes mediate calcium‐related neurotoxicity in Alzheimer's disease.
  • Microglia regulate neurodegeneration in Parkinson's disease through NO‐related apoptotic pathway.
  • Oligodendrocytes and Schwann cells regulate myelin wasting diseases in central and peripheral nervous system through Wnt and ErbB2/ErbB3 signalling pathways.
  • Glial cells form a scar following spinal cord injury that affects regenerative abilities.

Keywords: Glia; astrocytes; microglia; oligodendrocytes; Schwann cells; signal transduction; neurodegeneration; multiple sclerosis; nerve regeneration; glial scar

Figure 1. Glia signalling during neurological damage and disease. (a) In Alzheimer's disease, increased amyloid‐β load in the brain promotes Ca2+ channel expression on astrocytes. Glutamate released into the tripartite synapses trigger mGluR‐PLC‐IP3‐Ca2+ signalling, further elevating cytoplasmic Ca2+ concentration in astrocytes. The activated astrocytes increase the release of gliotransmitters, including glutamate, ATP, d‐serine and TNFα, to promote excitotoxicity in neurons. In Parkinson's disease, activated microglia that are exposed to α‐synuclein produce high level of iNOS, which release NO to cytosol of microglia and neurons. Increased NO activated Bax on the mitochondria, inducing the cytochrome c release, which then activate caspase 9‐mediated apoptosis pathway and neurodegeneration. NO also promote S‐nitrosylation modification of Ras, activating ERK pathway to increase the expression of TNFα and other cytokines, resulting in inflammation in microglia. (b) Wnt signalling is known to play an important role in multiple sclerosis pathology, but it is unclear whether this is a helpful or hurtful role. Binding of Wnt to Frizzled releases β‐catenin to travel into the nucleus and bind transcription factors such as Tcf. On the one hand, activation of the pathway may prevent maturation of OPCs into OLs and may suppress the transcription of myelin genes. On the other hand, this pathway has been implicated as having a necessary role in the transcription of myelin genes. See text for more details. (c) One major form of signalling in demyelinating CMT funnels through Nrg activation of the ErbB2/3 heterodimer. Activation of this pathway may have opposing effects. Signalling through the PLC route results in activation of promyelinating genes, whereas the MAPK pathway induces cell death through activation of JNK. See text for further description of other pathways. (d) The glial scar forms following axonal injury, surrounding the site of injury. It is composed of a basal lamina and activated astrocytes, bound by tight junctions. It serves as a physical barrier as well as a chemical one. The activated astrocytes secrete CSPGs, which are more highly concentrated at the site of injury and diffuse outwards. These are growth inhibitory factors and are received by Sema5a receptors on the surface of the axon, preventing growth cone extension. Myelin also begins to break apart, releasing other growth inhibitory molecules. Macrophages come in and clean up the myelin debris. This process intends to limit further neuronal degeneration and inflammatory effects.


Anderson MA, Burda JE, Ren Y, et al. (2016) Astrocyte scar formation aids central nervous system axon regeneration. Nature 532 (7598): 195–200.

Barres BA (2008) The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60 (3): 430–440.

Becker T and Becker CG (2014) Axonal regeneration in zebrafish. Current Opinion in Neurobiology 27: 186–191.

Boyd A, Zhang H and Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathologica 125 (6): 841–859.

Drac H, Kabzińska D, Moszyńska I, et al. (2011) Dysmyelinating and demyelinating Charcot–Marie–Tooth disease associated with two myelin protein zero gene mutations. Journal of Applied Genetics 52 (2): 177–183.

Fancy SPJ, Baranzini SE, Zhao C, et al. (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes & Development 23 (13): 1571–1585.

Ghosh S and Hui SP (2016) Regeneration of zebrafish CNS: adult neurogenesis. Neural Plasticity 2016: 1–21.

Guo F, Lang J, Sohn J, et al. (2015) Canonical Wnt signaling in the oligodendroglial lineage–puzzles remain. Glia 63 (10): 1671–1693.

Halliday GM, Stevens CH and Hons B (2011) Glia: initiators and progressors of pathology in Parkinson's disease. Movement Disorders 26 (1): 6–17.

Hammond E, Lang J, Maeda Y, et al. (2015) The Wnt effector transcription factor 7‐like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt/β‐catenin signaling. Journal of Neuroscience 35 (12): 5007–5022.

Hausmann ON (2003) Post‐traumatic inflammation following spinal cord injury. Spinal Cord 41: 369–378.

Jansen AHP, Reits EAJ and Hol EM (2014) The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Frontiers in Molecular Neuroscience 7 (73): 1–14.

Kantor DB, Chivatakarn O, Peer KL, et al. (2004) Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 44 (6): 961–975.

Kao S, Wu H, Xie J, et al. (2009) Calcineurin/NFAT signaling is required for neuregulin‐regulated Schwann cell differentiation. Science 323 (5914): 651–654.

Kim YS, Kim SS, Cho JJ, et al. (2005) Matrix metalloproteinase‐3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. Journal of Neuroscience 25 (14): 3701–3711.

Kucenas S, Takada N, Park H‐C, et al. (2008) CNS‐derived glia ensheath peripheral nerves and mediate motor root development. Nature Neuroscience 11 (2): 143–151.

Lastres‐Becker I, Ulusoy A, Innamorato NG, et al. (2012) α‐Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early‐stage Parkinson's disease. Human Molecular Genetics 21 (14): 3173–3192.

Lee SM, Chin L and Li L (2017) Dysregulation of ErbB receptor trafficking and signaling in demyelinating Charcot–Marie–Tooth disease. Molecular Neurobiology 54 (1): 87–100.

Lewis GM and Kucenas S (2014) Perineurial glia are essential for motor axon regrowth following nerve injury. Journal of Neuroscience 34 (38): 12762–12777.

Lim D, Iyer A, Ronco V, et al. (2013) Amyloid beta deregulates astroglial mGluR5‐mediated calcium signaling via calcineurin and Nf‐kB. Glia 61 (7): 1134–1145.

Lobsiger CS and Cleveland DW (2007) Glial cells as intrinsic components of non‐cell‐autonomous neurodegenerative disease. Nature Neuroscience 10 (11): 1355–1360.

Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430 (7000): 631–639.

Mokalled MH, Patra C, Dickson AL, et al. (2016) Injury‐induced ctgfa directs glial bridging and spinal cord regeneration in zebrafish. Science 354 (6312): 630–634.

Nagele RG, Wegiel J, Venkataraman V, et al. (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiology of Aging 25 (5): 663–674.

Nedergaard M, Rodríguez JJ and Verkhratsky A (2010) Glial calcium and diseases of the nervous system. Cell Calcium 47 (2): 140–149.

Nielsen HM, Mulder SD, Beliën JAM, et al. (2010) Astrocytic Aβ1‐42 uptake is determined by Aβ‐aggregation state and the presence of amyloid‐associated proteins. Glia 58 (10): 1235–1246.

Noseworthy JH, Lucchinetti C, Rodriguez M, et al. (2000) Multiple sclerosis. New England Journal of Medicine 343 (13): 938–952.

Ogata T, Iijima S, Hoshikawa S, et al. (2004) Opposing extracellular signal‐regulated kinase and Akt pathways control Schwann cell myelination. Journal of Neuroscience 24 (30): 6724–6732.

Parkinson DB, Bhaskaran A, Arthur‐Farraj P, et al. (2008) C‐Jun is a negative regulator of myelination. The Journal of Cell Biology 181 (4): 625–637.

Phatnani H and Maniatis T (2015) Astrocytes in neurodegenerative disease. Cold Spring Harbor Perspectives in Biology 7 (6): 1–17.

Podbielska M, Banik NL, Kurowska E, et al. (2013) Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sciences 3 (3): 1282–1324.

Przedborski S, Jackson‐Lewis V, Yokoyama R, et al. (1996) Role of neuronal nitric oxide in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced dopaminergic neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 93 (10): 4565–4571.

Qian L, Wu H, Chen SH, et al. (2011) β2‐Adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. Journal of Immunology 186 (7): 4443–4454.

Sandvig A, Berry M, Barrett LB, et al. (2004) Myelin‐, reactive glia‐, and scar‐derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46 (3): 225–251.

Silver J and Miller JH (2004) Regeneration beyond the glial scar. Nature Reviews Neuroscience 5 (2): 146–156.

Smith C, Morris A, Welsh T, et al. (2014) Contact‐mediated inhibition between oligodendrocyte progenitor cells and motor exit point glia establishes the spinal cord transition zone. PLoS Biology 12 (9): e1001961.

Teismann P, Tieu K, Cohen O, et al. (2003) Pathogenic role of glial cells in Parkinson's disease. Movement Disorders 18 (2): 121–129.

Vincent AJ, Gasperini R, Foa L, et al. (2010) Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity. Journal of Alzheimer's Disease 22 (3): 699–714.

Xie C, Li Z, Zhang G, et al. (2014) Wnt signaling in remyelination in multiple Sclerosis: friend or foe? Molecular Neurobiology 49 (3): 1117–1125.

Yiu G and He Z (2006) Glial inhibition of CNS axon regeneration. Nature Reviews Neuroscience 7 (8): 617–627.

Zemke D and Majid A (2004) The potential of minocycline for neuroprotection in human neurologic disease. Clinical Neuropharmacology 27 (6): 293–298.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Yong, Yu, Heckle, Lindsay A, Arena, Kimberly A, Goertz, Jennifer E, Kucenas, Sarah, and Deppmann, Christopher D(Aug 2017) Glia Signalling during Neurological Damage and Disease. In: eLS. John Wiley & Sons Ltd, Chichester. [doi: 10.1002/9780470015902.a0027501]